Roundtable Discussion: Comparing Manufacturing Paradigms Between AAV & Lentiviral Vectors

• Benchmarking productivity, scalability, and cost-effectiveness between AAV and LV manufacturing systems
• Evaluating upstream strategies: transient transfection vs. stable producer lines and implications for yield and consistency
• Assessing downstream purification challenges: recovery, impurity clearance, and platformability
• Identifying shared analytical standards and CQAs to ensure comparability across vector types

Speakers:

Sushmita “Mimi” Roy

Vice President - Technical Development & Chemistry, Manufacturing & Controls Operations

Rocket Pharmaceuticals Ltd.